Guidelines and the Role of Non-Statin Therapies for ASCVD Reduction in High Risk Patients — Addressing Statin Intolerance and Poor Target LDL-C Goal Attainment

Guidelines and the Role of Non-Statin Therapies for ASCVD Reduction in High Risk Patients — Addressing Statin Intolerance and Poor Target LDL-C Goal Attainment


Published

Created by

CMEducation Resources symposium